EPO and AL amyloidosis: Previous investigators also explored how EPO affected the immune status of patients with multiple myeloma and found that the immunomodulatory effects of EPO on lymphocytes, which lack the EPOR, were indirect and occurred by activating macrophages that express EPOR6.